Abstract
Plants of the Amaryllidaceae family have been under intense scrutiny for the presence of the specific metabolites responsible for the medicinal properties associated with them. The study began in 1877 with the isolation of alkaloid lycorine from Narcissus pseudonarcissus and since then more than 100 alkaloids, exhibiting diverse biological activities, have been isolated from the Amaryllidaceae plants. Based on the present scientific evidence, it is likely that isocarbostyril constituents of the Amaryllidaceae, such as narciclasine, pancratistatin and their congeners, are the most important metabolites responsible for the therapeutic benefits of these plant species in the folk medical treatment of cancer. Notably, Narcissus poeticus L., used by the ancient Greek physicians, is now known to contain about 0.12 g of narciclasine per kg of fresh bulbs. The focus of the present research work is the chemistry and biology of these compounds as specifically relevant to their potential use in medicine. In particular, the anticancer evaluation of lycorine, narciclasine as well as of other Amaryllidaceae alkaloids and their synthetic derivatives are presented in this paper. The structure–activity relationships among some groups of Amaryllidaceae alkaloids will be discussed.
Similar content being viewed by others
References
Abou-Donia AH, De Giulio A et al (1991) Narciclasine-4-O-β-D-glcopyranoside, a glucosyloxy amidic phenanthridone derivative from Pancratium maritmum. Phytochemistry 30:3445–3448. doi:10.1016/0031-9422(91)83226-B
Abou-Donia AH, Abib AZ et al (1992) Two beatine alkaloids from Egyptian Pancratium maritimum. Phytochemistry 31:2139–2141. doi:10.1016/0031-9422(92)80381-N
Arrigoni O, Arrigoni Liso R et al (1975) Lycorine as an inhibitor of ascorbic acid biosynthesis. Nature 256:513–514. doi:10.1038/256513a0
Ceriotti G (1967) Narciclasine: an antimitotic substances from Narcissus bulbs. Nature 213:595–596. doi:10.1038/213595a0
Cook JW, Loudon JD (1952) The alkaloids. Academic Press, New York
Evidente A (1991) Narciclasine: 1H- and 13C-NMR data and a new improved method of preparation. Planta Med 57:293–295. doi:10.1055/s-2006-960098
Evidente A, Motta A (2001) Bioactive metabolites from phytopathogenic bacteria and plants. In: Atta-ur-Rahaman (ed) Studies in natural products chemistry, vol 26. Elsevier, Amsterdam, pp 581–628 (and references therein cited)
Evidente A, Cicala MR et al (1983a) 1H and 13C NMR analysis of lycorine and α-dihydrolycorine. Phytochemistry 22:581–583. doi:10.1016/0031-9422(83)83051-9
Evidente A, Cicala MR et al (1983b) Lycorine structure-activity relationships. Phytochemistry 22:2193–2196. doi:10.1016/S0031-9422(00)80145-4
Evidente A, Iasiello I et al (1983c) Rapid quantitative analysis by reversed-phase high-performance liquid chromatography. J Chromatogr A 281:362–366. doi:10.1016/S0021-9673(01)87900-0
Evidente A, Iasiello I et al (1984) An improved method for large-scale preparation of lycorine. Chem Ind 348–349
Evidente A, Randazzo G et al (1985) Degradation of lycorine by Pseudomonas species strain ITM 311. J Nat Prod 48:564–570. doi:10.1021/np50040a008
Evidente A, Arrigoni O et al (1986) Further experiments on structure-activity relationships among the lycorine alkaloids. Phytochemistry 25:2739–2743. doi:10.1016/S0031-9422(00)83732-2
Evidente A, Abou-Donia AH et al (1999) Nobilisitine A and B, two masanane-type alkaloids from Clivia nobilis. Phytochemistry 51:1151–1155. doi:10.1016/S0031-9422(98)00714-6
Evidente A, Andolfi A et al (2004) (−)-Amarbellisine, a lycorine-type alkaloid from Amayllis belladonna L. growing in Egypt. Phytochemistry 65:2113–2118. doi:10.1016/j.phytochem.2004.03.020
Evidente A, Andolfi A et al (2005) Minor alkaloids from Clivia nobilis Regel. Alex J Pharm Sci 19:49–53
Evidente A, Kireev AS et al (2009) Biological evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta Med (in press)
Kornienko A, Evidente A (2008) Chemistry, biology, and medicinal potential of narciclasine and its congeners. Chem Rev 108:1982–2014. doi:10.1021/cr078198u (and references therein cited)
Kotera K, Hamada Y et al (1966) Absolute configuration of diastereomeric methiodides in the lycorine-type alkaloids. Tetrahedron Lett 50:6273–6278. doi:10.1016/S0040-4039(01)84143-5
Louw CAM, Regnier TC et al (2002) Medicinal bulbous plants of South Africa and their traditional relevance in the control of infectious disease. J Ethnopharmacol 82:147–154. doi:10.1016/S0378-8741(02)00184-8
Mondon A, Krohn K (1975) Chemistry of narciclasine. Chem Ber 108:445–463. doi:10.1002/cber.19751080210
Nagakawa Y, Uyeo S et al (1956) The double bond in lycorine. Chem Ind 1238–1239
Piozzi F, Fuganti C et al (1968) Narciclasine and narciprimine. Tetrahedron 24:1119–1131. doi:10.1016/0040-4020(68)88061-5
Piozzi F, Marino M et al (1969) Occurence of non-basic metabolites in Amaryllidaceae. Phytochemistry 8:1745–1748. doi:10.1016/S0031-9422(00)85963-4
Pettit GR, Melody N et al (1994) Antineoplastic agents. 321. Synthesis of 10b-R-hydroxypancratistatin via narciclasine. J Chem Soc Chem Commun 2725–2726. doi:10.1039/c39940002725
Pettit GR, Melody N et al (2002) Synthesis of 10b(R)-hydroxypancratistatin, 10b(S)-hydroxy-1-epipancratistatin, 10b(S)-hydroxy-1, 2-diepipancratistatin and related isocarbostyrils. Heterocycles 56:139–155
Wildman WC (1960) The alkaloids. Academic Press, New York
Acknowledgements
This work was carried out within the project “Programma di Scambi Internazionali con Università ed Istituti di Ricerca Stranieri per la Mobilità di Breve Durata di Docenti, Ricercatore e Studiosi”, which is financially supported by the Università di Napoli Federico II anno finanziario 2008. Contribution DISSPAPA 181.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Evidente, A., Kornienko, A. Anticancer evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives. Phytochem Rev 8, 449–459 (2009). https://doi.org/10.1007/s11101-008-9119-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11101-008-9119-z